Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Drug's heart safety checked in healthy volunteers

NCT ID NCT07422298

First seen Feb 21, 2026 · Last updated Jun 13, 2026 · Updated 15 times

Summary

This study checks if the experimental drug BMS-986278 affects the heart's electrical activity in 32 healthy adults aged 18 to 55. Participants receive multiple doses of the drug, a placebo, and a positive control in a crossover design. The main goal is to measure changes in heart rhythm (QTcF interval) to ensure the drug is safe for the heart.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Worldwide Clinical Trials

    RECRUITING

    San Antonio, Texas, 78217, United States

    Contact Phone: •••-•••-••••

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.